SHOESHINE: Investors may be repeating past Ryman mistakes
Are investors about to repeat the mistake they made about Ryman Healthcare during the global financial crisis?
Shoeshine Fri, 16 Dec 2016
Shoeshine is wondering whether investors are about to repeat the mistake they made about Ryman Healthcare during the global financial crisis.
Fearing the downturn in the housing market was going to hurt Ryman’s business and profits would tank, investors sold the shares from the peak at $2.75 in
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
